INSPIRE MEDICAL SYSTEMS INC (INSP) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:INSP - US4577301090 - Common Stock
94.45 USD
+2.22 (+2.41%)
94.69 USD
+0.24 (+0.25%)
Taking everything into account, INSP scores 6 out of 10 in our fundamental rating. INSP was compared to 186 industry peers in the Health Care Equipment & Supplies industry. INSP is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. INSP has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
- INSP had positive earnings in the past year.
- In the past year INSP had a positive cash flow from operations.
- INSP had negative earnings in 4 of the past 5 years.
- In multiple years INSP reported negative operating cash flow during the last 5 years.
1.2 Ratios
- INSP has a Return On Assets of 5.52%. This is amongst the best in the industry. INSP outperforms 82.26% of its industry peers.
- With an excellent Return On Equity value of 6.69%, INSP belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
- INSP has a Return On Invested Capital of 4.82%. This is in the better half of the industry: INSP outperforms 75.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROIC | 4.82% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 5.05%, INSP is in the better half of the industry, outperforming 77.42% of the companies in the same industry.
- INSP has a better Operating Margin (4.16%) than 68.82% of its industry peers.
- INSP's Gross Margin of 84.92% is amongst the best of the industry. INSP outperforms 94.09% of its industry peers.
- In the last couple of years the Gross Margin of INSP has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
2. Health
2.1 Basic Checks
- INSP has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, INSP has more shares outstanding
- INSP has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for INSP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- INSP has an Altman-Z score of 12.84. This indicates that INSP is financially healthy and has little risk of bankruptcy at the moment.
- INSP has a Altman-Z score of 12.84. This is amongst the best in the industry. INSP outperforms 91.40% of its industry peers.
- INSP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 12.84 |
ROIC/WACC0.48
WACC9.99%
2.3 Liquidity
- A Current Ratio of 5.29 indicates that INSP has no problem at all paying its short term obligations.
- INSP has a Current ratio of 5.29. This is amongst the best in the industry. INSP outperforms 81.18% of its industry peers.
- A Quick Ratio of 4.01 indicates that INSP has no problem at all paying its short term obligations.
- The Quick ratio of INSP (4.01) is better than 76.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 90.65% over the past year.
- INSP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.81%.
- The Revenue has been growing by 57.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
3.2 Future
- The Earnings Per Share is expected to grow by 18.80% on average over the next years. This is quite good.
- The Revenue is expected to grow by 11.14% on average over the next years. This is quite good.
EPS Next Y-17.67%
EPS Next 2Y1.09%
EPS Next 3Y13.97%
EPS Next 5Y18.8%
Revenue Next Year13.34%
Revenue Next 2Y12.16%
Revenue Next 3Y12%
Revenue Next 5Y11.14%
3.3 Evolution
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
- INSP is valuated quite expensively with a Price/Earnings ratio of 46.30.
- Compared to the rest of the industry, the Price/Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 69.89% of the companies listed in the same industry.
- INSP is valuated expensively when we compare the Price/Earnings ratio to 26.94, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 53.42, INSP can be considered very expensive at the moment.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of INSP indicates a somewhat cheap valuation: INSP is cheaper than 68.82% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 23.94. INSP is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.3 | ||
| Fwd PE | 53.42 |
4.2 Price Multiples
- 67.20% of the companies in the same industry are more expensive than INSP, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of INSP indicates a rather cheap valuation: INSP is cheaper than 82.80% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.78 | ||
| EV/EBITDA | 43.53 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as INSP's earnings are expected to grow with 13.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y1.09%
EPS Next 3Y13.97%
5. Dividend
5.1 Amount
- No dividends for INSP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
94.45
+2.22 (+2.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-12 2026-01-12/amc
Earnings (Next)02-11 2026-02-11/amc
Inst Owners111.59%
Inst Owner Change1.11%
Ins Owners0.74%
Ins Owner Change0.09%
Market Cap2.74B
Revenue(TTM)882.62M
Net Income(TTM)44.56M
Analysts80
Price Target142.79 (51.18%)
Short Float %10.13%
Short Ratio1.83
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)193.12%
Min EPS beat(2)114.53%
Max EPS beat(2)271.71%
EPS beat(4)4
Avg EPS beat(4)144.95%
Min EPS beat(4)54.07%
Max EPS beat(4)271.71%
EPS beat(8)8
Avg EPS beat(8)284.67%
EPS beat(12)12
Avg EPS beat(12)208.03%
EPS beat(16)16
Avg EPS beat(16)165.01%
Revenue beat(2)0
Avg Revenue beat(2)-0.43%
Min Revenue beat(2)-0.69%
Max Revenue beat(2)-0.17%
Revenue beat(4)1
Avg Revenue beat(4)-0.14%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)1.13%
Revenue beat(8)4
Avg Revenue beat(8)0.25%
Revenue beat(12)7
Avg Revenue beat(12)1.47%
Revenue beat(16)11
Avg Revenue beat(16)3.25%
PT rev (1m)11.46%
PT rev (3m)2.19%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-0.5%
EPS NY rev (1m)13.12%
EPS NY rev (3m)110.93%
Revenue NQ rev (1m)0.41%
Revenue NQ rev (3m)-0.45%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.26%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 46.3 | ||
| Fwd PE | 53.42 | ||
| P/S | 3.11 | ||
| P/FCF | 27.78 | ||
| P/OCF | 20.53 | ||
| P/B | 4.12 | ||
| P/tB | 4.12 | ||
| EV/EBITDA | 43.53 |
EPS(TTM)2.04
EY2.16%
EPS(NY)1.77
Fwd EY1.87%
FCF(TTM)3.4
FCFY3.6%
OCF(TTM)4.6
OCFY4.87%
SpS30.37
BVpS22.93
TBVpS22.93
PEG (NY)N/A
PEG (5Y)N/A
Graham Number32.44
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.52% | ||
| ROE | 6.69% | ||
| ROCE | 5.27% | ||
| ROIC | 4.82% | ||
| ROICexc | 8.98% | ||
| ROICexgc | 8.98% | ||
| OM | 4.16% | ||
| PM (TTM) | 5.05% | ||
| GM | 84.92% | ||
| FCFM | 11.2% |
ROA(3y)-1.48%
ROA(5y)-7.81%
ROE(3y)-1.66%
ROE(5y)-9.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.41%
GM growth 5Y0.33%
F-Score8
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 276.46% | ||
| Cap/Sales | 3.95% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 270.95% | ||
| Profit Quality | 221.78% | ||
| Current Ratio | 5.29 | ||
| Quick Ratio | 4.01 | ||
| Altman-Z | 12.84 |
F-Score8
WACC9.99%
ROIC/WACC0.48
Cap/Depr(3y)638.93%
Cap/Depr(5y)518.49%
Cap/Sales(3y)3.63%
Cap/Sales(5y)3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)90.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-43.33%
EPS Next Y-17.67%
EPS Next 2Y1.09%
EPS Next 3Y13.97%
EPS Next 5Y18.8%
Revenue 1Y (TTM)16.81%
Revenue growth 3Y50.95%
Revenue growth 5Y57.78%
Sales Q2Q%10.49%
Revenue Next Year13.34%
Revenue Next 2Y12.16%
Revenue Next 3Y12%
Revenue Next 5Y11.14%
EBIT growth 1Y172.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year656.93%
EBIT Next 3Y123.99%
EBIT Next 5Y70.56%
FCF growth 1Y1118.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y401.46%
OCF growth 3YN/A
OCF growth 5YN/A
INSPIRE MEDICAL SYSTEMS INC / INSP FAQ
What is the ChartMill fundamental rating of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to INSP.
Can you provide the valuation status for INSPIRE MEDICAL SYSTEMS INC?
ChartMill assigns a valuation rating of 4 / 10 to INSPIRE MEDICAL SYSTEMS INC (INSP). This can be considered as Fairly Valued.
How profitable is INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
INSPIRE MEDICAL SYSTEMS INC (INSP) has a profitability rating of 5 / 10.
What are the PE and PB ratios of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The Price/Earnings (PE) ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 46.3 and the Price/Book (PB) ratio is 4.12.
What is the financial health of INSPIRE MEDICAL SYSTEMS INC (INSP) stock?
The financial health rating of INSPIRE MEDICAL SYSTEMS INC (INSP) is 8 / 10.